scholarly article | Q13442814 |
P50 | author | Holly M Stradecki | Q82720606 |
P2093 | author name string | Umadevi V Wesley | |
Jane E Minturn | |||
Diane M Jaworski | |||
Patrick M Long | |||
P2860 | cites work | Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease | Q24321556 |
Essential roles of zinc ligation and enzyme dimerization for catalysis in the aminoacylase-1/M20 family | Q27641892 | ||
Human aminoacylase-1. Cloning, sequence, and expression analysis of a chromosome 3p21 gene inactivated in small cell lung cancer | Q28117175 | ||
Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase | Q28214332 | ||
Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture | Q28245251 | ||
Aspartoacylase is a regulated nuclear-cytoplasmic enzyme | Q28260283 | ||
Structural characterization, tissue distribution, and functional expression of murine aminoacylase III | Q28513747 | ||
Novel role for aspartoacylase in regulation of BDNF and timing of postnatal oligodendrogenesis | Q28579789 | ||
Structural characterization of dimeric murine aminoacylase III | Q28585000 | ||
The Zn-peptidase superfamily: functional convergence after evolutionary divergence | Q31402036 | ||
Improved immunocytochemical identification of neural, endothelial, and inflammatory cell types in paraffin-embedded injured adult rat spinal cord | Q33206522 | ||
Comprehensive characterization of neuroblastoma cell line subtypes reveals bilineage potential similar to neural crest stem cells | Q33409102 | ||
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group | Q33876841 | ||
Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas | Q34711600 | ||
Catabolism of intracellular N-terminal acetylated proteins: involvement of acylpeptide hydrolase and acylase | Q36145998 | ||
A novel chromosome abnormality in human neuroblastoma and antifolate-resistant Chinese hamster cell lives in culture | Q39404590 | ||
BDNF splice variants from the second promoter cluster support cell survival of differentiated neuroblastoma upon cytotoxic stress | Q39909863 | ||
Suppression of neuroblastoma growth by dipeptidyl peptidase IV: relevance of chemokine regulation and caspase activation. | Q39922341 | ||
Regulation of TIMP-2, MT1-MMP, and MMP-2 expression during C2C12 differentiation | Q40400276 | ||
Aminoacylase 1 is a sphingosine kinase 1-interacting protein | Q40545434 | ||
Aminoacylases | Q40693491 | ||
Infant cancer in the U.S.: histology-specific incidence and trends, 1973 to 1992. | Q40879652 | ||
Human and porcine aminoacylase I overproduced in a baculovirus expression vector system: evidence for structural and functional identity with enzymes isolated from kidney | Q41056002 | ||
Sudan Black B treatment reduces autofluorescence and improves resolution of in situ hybridization specific fluorescent signals of brain sections | Q43019354 | ||
Lack of aspartoacylase activity disrupts survival and differentiation of neural progenitors and oligodendrocytes in a mouse model of Canavan disease | Q43279304 | ||
Resistance to chemotherapy mediated by TrkB in neuroblastomas. | Q44220743 | ||
Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3'-kinase pathway. | Q44220786 | ||
Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for Neuroblastoma | Q44405256 | ||
Immunohistochemical localization of aspartoacylase in the rat central nervous system | Q44830875 | ||
Genome-wide analysis identifies a tumor suppressor role for aminoacylase 1 in iron-induced rat renal cell carcinoma. | Q46231620 | ||
Characterization of human neuroblastoma cell lines established before and after therapy. | Q52834184 | ||
Specificity of aminoacylase III-mediated deacetylation of mercapturic acids. | Q53596147 | ||
Neuroblastoma | Q54265665 | ||
Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas | Q93621132 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1322-1330 | |
P577 | publication date | 2011-04-01 | |
P1433 | published in | International Journal of Cancer | Q332492 |
P1476 | title | Differential aminoacylase expression in neuroblastoma | |
P478 | volume | 129 |
Q47148678 | Aminoacylase 3 Is a New Potential Marker and Therapeutic Target in Hepatocellular Carcinoma |
Q23916009 | ERK oscillation-dependent gene expression patterns and deregulation by stress response |
Q47790879 | Failure to Inactivate Nuclear GSK3β by Ser389-Phosphorylation Leads to Focal Neuronal Death and Prolonged Fear Response |
Q41553884 | Inhibition of aminoacylase 3 protects rat brain cortex neuronal cells from the toxicity of 4-hydroxy-2-nonenal mercapturate and 4-hydroxy-2-nonenal |
Q33645629 | Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patients |
Q40269056 | Replicated evidence for aminoacylase 3 and nephrin gene variations to predict antihypertensive drug responses. |
Q42001741 | Triacetin-based acetate supplementation as a chemotherapeutic adjuvant therapy in glioma. |
Search more.